摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(±)-6-(tert-butyl)-2-oxa-3-thia-4-azabicyclo[3.3.1]nonane 3,3-dioxide

中文名称
——
中文别名
——
英文名称
(±)-6-(tert-butyl)-2-oxa-3-thia-4-azabicyclo[3.3.1]nonane 3,3-dioxide
英文别名
6-(Tert-butyl)-2-oxa-3-thia-4-azabicyclo[3.3.1]nonane 3,3-dioxide;(1S,5S,6S)-6-tert-butyl-2-oxa-3λ6-thia-4-azabicyclo[3.3.1]nonane 3,3-dioxide
(±)-6-(tert-butyl)-2-oxa-3-thia-4-azabicyclo[3.3.1]nonane 3,3-dioxide化学式
CAS
——
化学式
C10H19NO3S
mdl
——
分子量
233.332
InChiKey
OGYWYJSKKNSYFY-YIZRAAEISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    63.8
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    (±)-cis-4-(tert-butyl)cyclohexyl sulfamate 在 silver hexafluoroantimonate 、 二(叔丁基羰基氧基)碘苯 、 [Mn(tBuPc)]Cl 作用下, 以 乙腈 为溶剂, 以90%的产率得到(±)-6-(tert-butyl)-2-oxa-3-thia-4-azabicyclo[3.3.1]nonane 3,3-dioxide
    参考文献:
    名称:
    GENERAL CATALYST FOR C-H FUNCTIONALIZATION
    摘要:
    该发明提供了新型的锰催化剂,如[Mn(tBuPc)],适用于所有类型的C(sp3)-H键(脂肪族、烯丙基、丙炔基、苄基、乙醚基)的胺化,包括强1°脂肪族C—H键,同时实现优异的化学选择性、立体特异性和高官能团耐受性。我们展示了包括选择性1°C—H键胺化在内的生物活性复合分子的晚期多样化,这些复合分子涵盖了各种C(sp3)-H键类型,如对苯二酚酸和普鲁莫铁霉素衍生物的选择性1°C—H键胺化。催化剂在反应性和选择性之间的前所未有的平衡部分归因于其C—H键胺化机制介于逐步和协同之间。
    公开号:
    US20160272662A1
点击查看最新优质反应信息

文献信息

  • A manganese catalyst for highly reactive yet chemoselective intramolecular C(sp3)–H amination
    作者:Shauna M. Paradine、Jennifer R. Griffin、Jinpeng Zhao、Aaron L. Petronico、Shannon M. Miller、M. Christina White
    DOI:10.1038/nchem.2366
    日期:2015.12
    is an outlier to the reactivity–selectivity paradigm. It is unique in its capacity to functionalize all types of C(sp3)–H bond intramolecularly, while displaying excellent chemoselectivity in the presence of π functionality. Mechanistic studies indicate that [Mn(tBuPc)] transfers bound nitrenes to C(sp3)–H bonds via a pathway that lies between concerted C–H insertion, observed with reactive noble metals
    C–H键氧化反应强调了现有的范例,其中高反应性和高选择性成反比。能够氧化强脂族C(sp 3)–H键同时显示化学选择性(即对更多可氧化官能度的耐受性)的催化剂的开发仍未解决。在这里,我们描述了一种催化剂叔丁基酞菁[Mn(t BuPc)],它与反应性-选择性范式是一个离群值。它在分子内功能化所有类型的C(sp 3)-H键的能力方面具有独特性,同时在存在π官能团的情况下表现出出色的化学选择性。力学研究表明[Mn(tBuPc)]通过协调的C–H插入(通过反应性贵属(如)观察到的C–H逐步逐步的C–H提取/反弹)之间的途径将结合的氮烯转移至C(sp 3)–H键。等贱属。[Mn(t BuPc)]并没有实现效果的混合,甚至使1°的脂族和炔丙基C–H键基化,证明了以前已知的催化剂不寻常的反应性和选择性。
  • US9770711B2
    申请人:——
    公开号:US9770711B2
    公开(公告)日:2017-09-26
查看更多

同类化合物

甜蜜素 环拉酸 异米尼尔环璜酸盐 二环己基氨基磺酸 4-[(2S)-2-氨基-4-(甲基硫烷基)丁酰]-L-α-谷氨酰-3-(4H-咪唑-4-基)-L-丙氨酰-L-苯丙氨酸 4-(二甲基氨基)-2-异丙基-2-苯基戊腈环璜酸盐 5-methyl-2-(1-methylethyl)cyclohexyl (3aR,7aS)-rel-hexahydro-1,2,3-benzothiazole-3(3aH)-carboxylate 2,2-dioxide 5-methyl-2-(1-methylethyl)cyclohexyl (3aR,7aS)-rel-hexahydro-1,2,3-benzothiazole-3(3aH)-carboxylate 2,2-dioxide [(1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexyl] 2,2-dioxo-3a,4,5,6,7,7a-hexahydrobenzo[d]oxathiazole-3-carboxylate 5,6-dihydro-1'-(2-thienyl-methyl)spiro[imidazo[2,1-b][3]benzazepine-11-[11H],4'-piperidine] cyclohexylsulfamate (1:1) 2,2,2-trichloroethyl cyclohexylsulfamate [Bi(CycH)3] (-)-3,18-(2,2-dioxido-1,2,3-oxathiazinan-3-yl)-13-methyl-17-norkauran-16-one ethylmethyl-5-(tetrahydro-2-furanyl)pentylsulfonium cyclohexylsulfamate Phenylephrine cyclohexylsulfamate Magnesium cyclamate Silver cyclamate Sulfamic acid, (3-methylcyclohexyl)- 2-(p-Methoxy-alpha-(1-piperidyl)benzyl)cyclohexanol cyclohexanesulfamate Barium cyclohexanesulfamate Butyranilide, 2'-ethyl-3-(2-methoxyethyl)amino-3-methyl-, cyclohexane sulfamate 1-(4-Cyclopropyl-phenyl)-2-methylamino-ethanol; compound with cyclohexyl-sulfamic acid Cyclohexylsulfamic acid--3-(1-butylpyrrolidin-2-yl)-1H-indole (1/1) Cyclohexylsulfamic acid--1-benzyl-3-(1-methylpyrrolidin-2-yl)-1H-indole (1/1) (+)-Furfurylmethyl(alpha-methylphenethyl)ammonium cyclohexylsulphamate Cyclamate magnesium dihydrate potassium cyclohexylsulfamate Cyclohexylsulfamic acid--1-(4-chlorophenyl)-N-[(furan-2-yl)methyl]-N-methylpropan-2-amine (1/1) Cyclohexylsulfamic acid--N-[(furan-2-yl)methyl]-N-methyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine (1/1) Calcium cyclamate N-Nitrosocyclohexylsulfamic acid 3,4,5,6-tetrahydro-6-methyl-3-benzylspiro[1,2,3-oxathiazine-2,2-dioxide-4-cyclohexane] (R)-1,1,1-Trichloro-4-(hex-5-yn-1-ylamino)-4-oxobutan-2-yl (5R,8R)-8-methyl-4-methylene-7-oxo-2-azabicyclo[3.3.1]nonane-2-sulfonate ethanol-cyclam (2S,3R)-2,3-dihydroxy-3-phenyl-1-[(1S,2R,6S,7R)-7,10,10-trimethyl-4,4-dioxo-3-oxa-4lambda6-thia-5-azatricyclo[5.2.1.02,6]decan-5-yl]propan-1-one (2S)-2,3-dihydroxy-1-[(1S,2R,6S,7R)-7,10,10-trimethyl-4,4-dioxo-3-oxa-4lambda6-thia-5-azatricyclo[5.2.1.02,6]decan-5-yl]propan-1-one 2,2,2-Trichloroethyl 2,2-dioxo-3-oxa-2lambda6-thia-1,4-diazaspiro[5.5]undecane-4-carboxylate (2S,3R)-3-cyclohexyl-2,3-dihydroxy-1-[(1S,2R,6S,7R)-7,10,10-trimethyl-4,4-dioxo-3-oxa-4lambda6-thia-5-azatricyclo[5.2.1.02,6]decan-5-yl]propan-1-one Sodium dicyclohexylsulfamate Sodium N-ethylcyclohexylsulfamate Barium(2+);cyclohexylsulfamic acid 2,2,2-Trichloroethyl 7-azabicyclo[4.1.0]heptane-7-sulfonate (2-oxo-cyclohexyl)sulfamic acid 2,2,2-trichloroethyl ester [(1S,2R,5S,7S,10S,11S,13R,17S,20R)-10,20-dimethyl-15,15-dioxo-16-oxa-15lambda6-thia-14-azapentacyclo[11.6.1.02,11.05,10.017,20]icosan-7-yl]oxy-tri(propan-2-yl)silane methyl 1-benzyl-3-pyrrolidineacetate cyclohexylsulfamate 2,2,2-Trichloroethyl 3-azatricyclo[3.2.1.02,4]octane-3-sulfonate [(2R)-3-carboxy-2-hydroxypropyl]-trimethylazanium;N-cyclohexylsulfamate azane;cyclohexylsulfamic acid (1,2,3-Trimethylcyclohexyl)sulfamic acid Beta-diethylaminoethyl-p-aminobenzoate cyclohexylsulfamate